Mailankody, Sharada <br/><br/>
Cerebrospinal fluid matrix metalloproteinase 9 levels, blood-brain barrier permeability, and treatment outcome in tuberculous meningitis.  [electronic resource] 

 -  PloS one  2017 
 - e0181262 p.  digital 
<br/><br/> Publication Type: Controlled Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0181262  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Biomarkers--cerebrospinal fluid<br/>Blood-Brain Barrier--metabolism<br/>Capillary Permeability<br/>Female<br/>Humans<br/>Male<br/>Matrix Metalloproteinase 9--cerebrospinal fluid<br/>Middle Aged<br/>Tissue Inhibitor of Metalloproteinase-1--cerebrospinal fluid<br/>Treatment Outcome<br/>Tuberculosis, Meningeal--cerebrospinal fluid